A Randomized Placebo controlled Phase I/II Study Evaluating the Safety and Efficacy of Alpha1H in adult patients with non-muscle invasive bladder cancer awaiting transurethral surgery
Phase of Trial: Phase I/II
Latest Information Update: 13 Sep 2019
Price : $35 *
At a glance
- Drugs Alpha lactalbumin oleic acid (Primary)
- Indications Bladder cancer
- Focus Adverse reactions; Biomarker; First in man; Therapeutic Use
- Sponsors Hamlet Pharma AB
- 20 Aug 2019 Planned number of patients changed from 40 to 52.
- 20 Aug 2019 Planned End Date changed from 1 Mar 2019 to 1 Mar 2022.
- 20 Aug 2019 Planned primary completion date changed from 1 Mar 2019 to 1 Mar 2020.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History